CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues ($M)
Quarterly figures from Cvs Health's filings and investor materials
Latest, Q3 2026
50,647
Period ended Sep 30, 2026
Change on a year earlier
+1.9%
49,690 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
2
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 50,647 | +1.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2026 | Jun 30, 2026 | 53,579 | +9.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2026 | Mar 31, 2026 | 49,944 | +7.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2025 | Dec 31, 2025 | 49,725 | +21.9% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2025 | Sep 30, 2025 | 49,690 | +18.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2025 | Jun 30, 2025 | 48,742 | +22.4% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2025 | Mar 31, 2025 | 46,620 | +15.4% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2024 | Dec 31, 2024 | 40,805 | +3.4% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2024 | Sep 30, 2024 | 42,023 | +10.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2024 | Jun 30, 2024 | 39,836 | +5.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2024 | Mar 31, 2024 | 40,407 | +3.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2023 | Dec 31, 2023 | 39,460 | +11.0% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2023 | Sep 30, 2023 | 38,042 | +6.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2023 | Jun 30, 2023 | 37,608 | +4.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2023 | Mar 31, 2023 | 38,889 | +4.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2022 | Dec 31, 2022 | 35,561 | +9.2% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2022 | Sep 30, 2022 | 35,865 | +10.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2022 | Jun 30, 2022 | 35,936 | +15.8% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2022 | Mar 31, 2022 | 37,185 | +24.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2021 | Dec 31, 2021 | 32,568 | +15.1% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2021 | Sep 30, 2021 | 32,406 | +11.4% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2021 | Jun 30, 2021 | 31,025 | +12.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2021 | Mar 31, 2021 | 29,983 | +15.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2020 | Dec 31, 2020 | 28,288 | +50.0% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2020 | Sep 30, 2020 | 29,090 | +53.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2020 | Jun 30, 2020 | 27,712 | +51.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2020 | Mar 31, 2020 | 26,025 | +41.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2019 | Dec 31, 2019 | 18,863 | +13.9% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2019 | Sep 30, 2019 | 18,976 | +17.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2019 | Jun 30, 2019 | 18,356 | +29.4% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2019 | Mar 31, 2019 | 18,444 | +39.8% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2018 | Dec 31, 2018 | 16,559 | +29.3% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2018 | Sep 30, 2018 | 16,182 | +36.0% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q2 2018 | Jun 30, 2018 | 14,181 | +18.6% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q1 2018 | Mar 31, 2018 | 13,194 | +12.5% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q4 2017 | Dec 31, 2017 | 12,806 | +7.5% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2017 | Sep 30, 2017 | 11,898 | +9.7% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q2 2017 | Jun 30, 2017 | 11,954 | +9.7% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q1 2017 | Mar 31, 2017 | 11,724 | +68.6% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q4 2016 | Dec 31, 2016 | 11,911 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2016 | Sep 30, 2016 | 10,846 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q2 2016 | Jun 30, 2016 | 10,897 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q1 2016 | Mar 31, 2016 | 6,953 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
Breakdown
What makes up peer benchmark — centene corporation (cnc, through q3 2026): total revenues
Cite this data
StockData. (2026). Cvs Health Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_cnc_revenue
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.